131 related articles for article (PubMed ID: 18317610)
1. Psychosocial, health and demographic characteristics of quality of life among patients with acute myeloid leukemia and malignant lymphoma who underwent autologous hematopoietic stem cell transplantation.
Slovacek L; Slovackova B; Jebavy L; Macingova Z
Sao Paulo Med J; 2007 Nov; 125(6):359-61. PubMed ID: 18317610
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis.
Slovacek L; Slovackova B; Pavlik V; Hrstka Z; Macingova Z; Jebavy L; Horacek JM
Neoplasma; 2008; 55(4):350-5. PubMed ID: 18505348
[TBL] [Abstract][Full Text] [Related]
3. Global quality of life in patients who have undergone the hematopoietic stem cell transplantation: finding from transversal and retrospective study.
Slovacek L; Slovackova B; Jebavy L
Exp Oncol; 2005 Sep; 27(3):238-42. PubMed ID: 16244589
[TBL] [Abstract][Full Text] [Related]
4. The effect of selected health, demographic and psychosocial aspects on quality of life in patients with peripheral arterial occlusive disease--a prospective analysis.
Slovácek L; Slováková B; Chovanec V; Vacková P; Kaslíková M; Bohutínská H; Jebavý L
Acta Medica (Hradec Kralove); 2007; 50(2):125-7. PubMed ID: 18035750
[TBL] [Abstract][Full Text] [Related]
5. The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study.
Valkova V; Jircikova J; Trnkova M; Steinerova K; Keslova P; Lanska M; Koristek Z; Raida L; Krejci M; Kruntoradova K; Dolezal T; Benesova K; Cetkovsky P; Trneny M
Neoplasma; 2016; 63(5):743-51. PubMed ID: 27468878
[TBL] [Abstract][Full Text] [Related]
6. [Health and psychosocial aspects of quality of life in patients undergoing autologous progenitor stem cell transplantation].
Slovácek L; Slováková B; Jebavý L
Cas Lek Cesk; 2006; 145(12):949-52; discussion 953-4. PubMed ID: 17323618
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in adult patients treated with peripheral blood progenitor cell transplantation: the effect of selected psychosocial, demographics and health aspects on quality of life: a retrospective analysis.
Slovácek L; Slovácková B; Jebavý L; Pavlík V
Acta Medica (Hradec Kralove); 2007; 50(2):119-24. PubMed ID: 18035749
[TBL] [Abstract][Full Text] [Related]
8. Impaired health-related quality of life in acute myeloid leukemia survivors: a single-center study.
Leunis A; Redekop WK; Uyl-de Groot CA; Löwenberg B
Eur J Haematol; 2014 Sep; 93(3):198-206. PubMed ID: 24673368
[TBL] [Abstract][Full Text] [Related]
9. Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument.
Wettergren L; Sprangers M; Björkholm M; Langius-Eklöf A
Psychooncology; 2008 Apr; 17(4):338-46. PubMed ID: 17614094
[TBL] [Abstract][Full Text] [Related]
10. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575
[TBL] [Abstract][Full Text] [Related]
11. Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy.
Brandt J; Dietrich S; Meissner J; Neben K; Ho AD; Witzens-Harig M
Leuk Lymphoma; 2010 Nov; 51(11):2012-20. PubMed ID: 20858092
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
13. Quality of life from the perspective of the patient with acute myeloid leukemia.
Buckley SA; Jimenez-Sahagun D; Othus M; Walter RB; Lee SJ
Cancer; 2018 Jan; 124(1):145-152. PubMed ID: 28881384
[TBL] [Abstract][Full Text] [Related]
14. Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
Brissot E; Labopin M; Stelljes M; Ehninger G; Schwerdtfeger R; Finke J; Kolb HJ; Ganser A; Schäfer-Eckart K; Zander AR; Bunjes D; Mielke S; Bethge WA; Milpied N; Kalhs P; Blau IW; Kröger N; Vitek A; Gramatzki M; Holler E; Schmid C; Esteve J; Mohty M; Nagler A
J Hematol Oncol; 2017 Jun; 10(1):130. PubMed ID: 28646908
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing life satisfaction in acute myeloid leukemia survivors following allogeneic stem cell transplantation: a cross-sectional study.
Amler S; Sauerland MC; Deiters C; Büchner T; Schumacher A
Health Qual Life Outcomes; 2015 Feb; 13():28. PubMed ID: 25888906
[TBL] [Abstract][Full Text] [Related]
16. Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
Baron F; Gothot A; Salmon JP; Hermanne JP; Pierard GE; Fillet G; Beguin Y
Br J Haematol; 2000 Dec; 111(3):745-53. PubMed ID: 11122133
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
[TBL] [Abstract][Full Text] [Related]
18. Outcome of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with central nervous system involvement.
Aoki J; Ishiyama K; Taniguchi S; Fukuda T; Ohashi K; Ogawa H; Kanamori H; Eto T; Iwato K; Sakamaki H; Morishima Y; Nagamura T; Atsuta Y; Takami A
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2029-33. PubMed ID: 25196856
[TBL] [Abstract][Full Text] [Related]
19. Donor Killer Immunoglobulin-Like Receptor Profile Bx1 Imparts a Negative Effect and Centromeric B-Specific Gene Motifs Render a Positive Effect on Standard-Risk Acute Myeloid Leukemia/Myelodysplastic Syndrome Patient Survival after Unrelated Donor Hematopoietic Stem Cell Transplantation.
Bao X; Wang M; Zhou H; Zhang H; Wu X; Yuan X; Li Y; Wu D; He J
Biol Blood Marrow Transplant; 2016 Feb; 22(2):232-239. PubMed ID: 26371372
[TBL] [Abstract][Full Text] [Related]
20. [Hematopoietic stem cell transplantation for hematological malignancies].
Zhong MZ; Chen FP; Shu YG
Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):242-4. PubMed ID: 12575304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
